| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.064 | 0.8 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.093 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.8 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.014 | 0.8 |